VRDN

VRDN

USD

Viridian Therapeutics Inc. Common Stock

$22.550-0.170 (-0.748%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$22.720

Hoch

$23.050

Tief

$22.140

Volumen

4.98M

Unternehmensfundamentaldaten

Marktkapitalisierung

2.1B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.03M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $9.9Aktuell $22.550Hoch $27.2

Ähnliche Nachrichten

Analyst Upgrades

BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target

BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.

Mehr anzeigen
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BusinessWire

Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease

- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports

Mehr anzeigen
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease